Greg Shanahan

Greg Shanahan is a prominent figure in the start-up community, known for founding the Technology Investment Network (TIN) and the Auckland med-tech firm Veriphi, which focuses on developing AI-driven analysers for intravenous medication verification. Recently, Veriphi signed its first commercial supply agreement with St Vincent’s Hospital Melbourne, marking a significant milestone as it begins to generate export revenue. Shanahan aims to scale the company into a billion-dollar enterprise, targeting the substantial market for IV drug delivery solutions.